Madopar

Medicinal product

(Invented) name

Madopar

Active substance (s)

Levodopa/Benserazidas

Strength

200 mg/50 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

UAB Roche Lietuva, Lietuva

Date of authorisation

1994-03-31

Date of renewal

2007-11-30

Documents

0936 Madopar, Madopar HBS RPP 2024 04 03.docx

0936 Pakuotės lapelis 2024 04 03.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Levodopa	200 mg
Benserazidas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
13484	1213	1001213	buteliukas	N100		Receptinis	LT/1/94/0936/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2007-11-30	Perregistruotas
1994-03-31	Registruotas